Arcus Biosciences
Biotech · Private
Small-molecule inhibitors targeting the adenosine immunosuppression pathway for cancer immunotherapy
arcusbio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 23 granted · 17 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1163 | AnkyrBio LLC | — | — |
| 1164 | YOURCHOICE THERAPEUTICS INC | — | — |
| 1165 | ABALONE BIO, INC. | — | — |
| 1166 | Arcus Biosciences | — | — |
| 1167 | LARIX BIOSCIENCE LLC | — | — |
| 1168 | Neumentum, Inc. | — | $27M |
| 1169 | Tioga Pharmaceuticals Inc | — | $24M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Treating Solid Tumors Using An ANTI-PD-1 Antibody Or A Fragment Thereofgranted
- Inhibitors Of HPK1 And Methods Of Use Thereofgranted
- Modulators Of 5'-NUCLEOTIDASE, Ecto And The Use Thereofapplication
- Processes For Preparing Aminopyrimidine Compoundsgranted
- Piperidylurea Compounds And Methods Of Use Thereofgranted
- Cbl-b Inhibitors And Methods Of Use Thereofapplication
- Treatment Of Oncogene-driven Cancersapplication
- Dispersions Of Etrumadenantapplication
- Cbl-b Inhibitors And Methods Of Use Thereofapplication
- Treatment Of Cancer Utilizing An Identified Adenosine Fingerprintapplication
- Modulators Of 5'-NUCLEOTIDASE, Ecto And The Use Thereofgranted
- Treatment Of Oncogene-driven Cancersgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.